| abstract |
A serum cholesterol lowering agent or atherosclerosis preventative or therapeutic agent, each of which comprises a combination of a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof with a cholesterol biosynthesis inhibitor and / or a fibrate-type cholesterol lowering agent. (I) (b) (a) [In the formula, A 1, A 3 and A 4 are each hydrogen, a group represented by formula (b), or a group represented by formula (a), provided that at least one of these is a group represented by by formula (a); A2 is C1.5 alkyl etc; and n, p, q and r are each an integer of 0.1 or 2] |